newsfilter
← Latest News
PR Newswire·

Invitae to Appeal Trial Verdict

SAN FRANCISCO, May 15, 2023 /PRNewswire/ -- Invitae (NYSE:NVTA), a leading medical genetics company, today announced that it intends to appeal the verdict delivered by a jury at the United States District Court for the